Dr. Craig Eagle of the Regenicin Board of Directors Attends The World Stem Cells and Regenerative Medicine Congress 2011
07 Junho 2011 - 11:13AM
Marketwired
Regenicin, Inc. (OTCBB: RGIN) announces today that Dr. Craig Eagle
who sits on the Regenicin Board of Directors, attended The World
Stem Cells and Regenerative Medicine Congress 2011 in efforts to
further Regencin's push towards obtaining FDA approval for the
commercial sale of its first product candidate.
The World Stem Cells and Regenerative Medicine
Congress is a senior director-level, interactive conference
experience. Speakers and panelists are industry leaders from
throughout Europe, North America and Asia. The World Stem Cells and
Regenerative Medicine Congress is Europe's most progressive
strategic conference where ideas, intelligence and relationships
really make a difference.
"The World Stem Cells and Regenerative Medicine Congress plays a
vital role in advancing awareness of the most ground-breaking
developments in the field, recognizing key industry leaders, and
facilitating top level conversations about strategic planning and
partnerships," says Randall McCoy, CEO of Regenicin. "It is great
to see that Regenicin is perfectly in line with stem cell
technology that is being pursued by the rest of the world."
About Regenicin, Inc. Regenicin, Inc. is a
biotechnology company with corporate headquarters in Little Falls,
New Jersey. The Company specializes in the development of
regenerative cell therapies to restore the health of damaged
tissues and organs.
Safe Harbor This press release contains certain forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, which are intended to be covered by the safe harbors
created thereby. Investors are cautioned that all forward-looking
statements involve risks and uncertainties, including, without
limitation, the future press releases of Regenicin, Inc.
Add to Digg Bookmark with del.icio.us Add to Newsvine
CONTACT: Randall McCoy Email Contact
Regenicin (CE) (USOTC:RGIN)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Regenicin (CE) (USOTC:RGIN)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre Regenicin Inc (CE) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Regenicin, Inc.